Clinical Trial

A Clinical Study of SYS6041 Combination Therapy for Recurrent Ovarian Cancer

Name: A Clinical Study of SYS6041 Combination Therapy for Recurrent Ovarian Cancer — clinical trial record (NCT07714668)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

This is an open-label, multicenter Phase II clinical study conducted in subjects with recurrent ovarian cancer.

Trial Details

NCT Number	NCT07714668
Lead Sponsor	CSPC Megalith Biopharmaceutical Co.,Ltd.
Conditions	Ovarian Cancer, Recurrent Ovarian Cancer
Enrollment	171 participants
Start Date	2026-08-31
Primary Completion	2028-04-30 (estimated)
Study Completion	2029-08-31 (estimated)
Updated on ClinicalTrials.gov	2026-07-20